Traditional Chinese medicine and epigenetics: an ethnopharmacological review of botanical drugs and plant metabolites
Year: 2026
Type: article
Abstract: Epigenetic mechanisms—DNA methylation, histone modifications, non-coding RNA activity, N6-methyladenosine (m6A) RNA modification and ATP-dependent chromatin remodelling—regulate gene expression without altering the underlying DNA sequence, and they respond to environmental and pharmacological stimuli. Traditional Chinese Medicine (TCM) selects multi-botanical-drug preparations according to syndrome patterns (zheng) rather than biomedical disease categories, and epigenetics has been proposed as a framework within which the action of such preparations might be examined. We reviewed the literature as two related but distinct evidence streams: 76 study-level reports covering 59 distinct interventions, comprising 26 multi-botanical-drug formulas, seven extracts of a single botanical drug, one metabolite–botanical drug combination, 41 isolated plant metabolites or metabolite mixtures, and one derived peptide. Because ConPhyMP addresses plant material and its extracts, we applied it only to the 34 botanical-drug preparations, and audited the isolated metabolites separately for provenance and for specificity to the Chinese materia medica. Botanical authentication, drug-to-extract ratios, chromatographic fingerprints and marker-metabolite quantification were available for a minority of the 34 preparations, and no study compared two batches of the same preparation. On a nine-level evidence scale, 59 of 76 reports reached grade 5 (perturbational dependence) and one reached grade 9 (randomised trial); none reached grade 6, at which an epigenetic change is shown to mediate a phenotypic effect. Six of the most frequently studied metabolites—curcumin, resveratrol, epigallocatechin-3-gallate, quercetin, luteolin and kaempferol—are major metabolites of cosmopolitan food plants, which limits how far their effects can be generalised to TCM practice. Epigenetics remains a plausible and testable framework for TCM botanical drugs, and advancing it will depend on ConPhyMP-compliant reporting and on formula-level designs that can compare a preparation with its individual metabolites.
Source: Frontiers in Pharmacology
Authors: Haoyu Chen, Qi Li, Hangyu Chen, Jian Lin, Yangang Wang
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Keywords: traditional Chinese medicine, epigenetics, plant-derived drugs, plant metabolites, DNA methylation, histone modifications, N6-methyladenosine, non-coding RNA, chromatin remodeling, Chinese materia medica, curcumin, resveratrol, epigallocatechin gallate, flavonoids, plant authentication, chromatographic fingerprint
Open Access status: gold
Estimated APC paid: $3,801
Award: G327662738
OpenAlex ID: W7233747101
